1453416-64-2

Basic information

• Product Name: C₃₁H₃₃N₅O₄S₂
• Synonyms: C₃₁H₃₃N₅O₄S₂
• CAS NO: 1453416-64-2
• Molecular Weight: 603.766
• Mol File: 1453416-64-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₃₁H₃₃N₅O₄S₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₁H₃₃N₅O₄S₂(1453416-64-2)
• EPA Substance Registry System: C₃₁H₃₃N₅O₄S₂(1453416-64-2)

Safety Data

• Hazardous Substances Data: 1453416-64-2(Hazardous Substances Data)

Upstream product

• 87691-88-1 3-(1-piperazinyl)-1,2-benzisothiazole hydrochloride 
• 117997-81-6 5-(benzyloxy)-2-(tert-butoxycarbonylamino)-5-oxopentanoic acid 
• 1446419-88-0 C₂₈H₃₄N₄O₅S 
• 1453417-04-3 C₂₃H₂₆N₄O₃S*C₂HF₃O₂ 
• 3288-04-8 1-isothiocyanato-2-methoxybenzene 

Relevant articles and documents

Ureas/thioureas of benzo[d]isothiazole analog conjugated glutamic acid: Synthesis and biological evaluation

A series of urea and thiourea derivatives of glutamic acid conjugated to 3-(1-piperazinyl)-1,2-benzisothiazole were synthesized, spectroscopically characterized, and evaluated for their in vitro antiglycation and urease inhibitory activities. Preliminary screening of the synthesized compounds 1-35 showed significant results. Amongst these, compounds 17-21 and 30-35 bearing fluoro and methoxy substituents, respectively, exhibited inhibitory potency greater than the reference standards. Hence, they may serve as new lead compounds for further development. Urea and thiourea derivatives of glutamic acid conjugated to 3-(1-piperazinyl)-1,2-benzisothiazole were evaluated for their in vitro antiglycation and urease inhibitory activities. Compounds 17-21 and 30-35 bearing fluoro and methoxy substituents, respectively, exhibited inhibitory potency greater than the reference compounds. Copyright